| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.29 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |